Sterigenics International LLC Changes Name to Sotera Health LLC
Sterigenics International LLC (the “Company”) announced today that it has changed its parent company name to Sotera Health LLC. Its three operating companies – Nelson Labs™, Nordion® and Sterigenics® – will continue to maintain their current names. The new parent company name signals a more integrated and holistic customer value proposition as it combines the offerings of three best-in-class companies to better serve customers with a more comprehensive offering of mission-critical services.
The name Sotera was inspired by the Greek goddess of safety, Soteria, and reflects the Company’s unwavering commitment to global health. As the global leader in mission-critical services to ensure the safety of healthcare, Sotera Health has 62 facilities in 13 countries and provides rigorous lab services, comprehensive sterilization solutions and a reliable global supply of radioisotopes to the medical device, pharmaceutical, tissue and food industries. The company touches the lives of more than 180 million people around the world each year and serves over 6,000 global customers, including 75% of the top 100 medical device manufacturers.
“Safeguarding Global Health™ is the cornerstone of our new brand and guides us in what we do each and every day,” said Michael B. Petras Jr., CEO of Sotera Health. “It speaks to the breadth of our business and our ability to partner with our customers across their entire product-development lifecycle.”
The new brand was developed after an extensive process of in-depth engagement with customers, suppliers, employees and Company leadership. The companies and services under the Sotera Health umbrella are:
- Nelson Labs is the industry-leading provider of global lab testing and expert consulting services. Nelson Labs performs over 400 rigorous microbiological and analytical laboratory tests across the medical device, pharmaceutical and tissue industries. The company is regarded as a best-in-class partner with a strong track record of collaborating with customers to solve complex issues. Most recently, the company announced the acquisition of Toxikon Europe, which, in combination with Nelson Labs, will create the leading global extractables and leachables lab testing platform.
- Nordion is the leading global provider of mission-critical radioisotopes used for the prevention, diagnosis and treatment of disease. Nordion ensures the reliable supply of Cobalt-60, the primary input to the gamma sterilization process, to the leaders in healthcare, including sister company Sterigenics.
- Sterigenics is the leading global provider of comprehensive sterilization solutions that eliminate potential health threats, using the most advanced and reliable medical sterilization techniques available. Sterigenics has deep expertise across Gamma, Ethylene Oxide (EO), Electron Beam (E-beam) and X-ray sterilization.
“Our new brand underscores the customers’ recognition of our more expansive partnership as they innovate in an ever-changing and increasingly regulated healthcare world,” added Petras. “We look forward to providing them with the same best-in-class service, quality and expertise in a more integrated service offering.”
About Sotera Health:
Sotera Health LLC, along with its business entities, is the world’s leading, fully integrated protector of global health. With over 500 years of combined scientific expertise, the company ensures the safety of healthcare by providing mission-critical services to the medical device, pharmaceutical, tissue and food industries. Sotera Health operates more than 62 facilities in 13 countries. The company has over 2,800 employees globally and touches the lives of more than 180 million people around the world each year. Sotera Health serves more than 6,000 customers worldwide including 75 of the top 100 medical device manufacturers.
Sotera Health goes to market through its three best-in-class companies – Nelson Labs™, Nordion® and Sterigenics® - with the mission of ensuring the safety of healthcare each and every day. Nelson Labs, along with recently acquired Toxikon Europe, offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and the pharmaceutical and biologics fields. Nordion is the world’s largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Sterigenics provides comprehensive contract sterilization and ionization solutions for the medical device, pharmaceutical, food safety and high-performance materials industries.
Sotera Health LLC is owned by private equity firms Warburg Pincus and GTCR. Learn more about Sotera Health at soterahealth.com, about Nelson Labs at nelsonlabs.com, about Nordion at nordion.com and about Sterigenics at sterigenics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171107006174/en/
Contact information
Dix & Eaton
Amy McGahan, 216-241-3027
amcgahan@dix-eaton.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer24.6.2025 08:05:00 EEST | Press release
The Bloom Brand, a recognized U.S. leader in cannabis vape, is making its international debut in the United Kingdom through an exclusive partnership with New Garden Pharma, a leading European EU-GMP cannabis operator. Together, the two companies will launch Bloom’s award-winning Classic and Live vape collections in the UK in Q1 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623573625/en/ This marks Bloom’s first international market expansion, as the company continues its global growth strategy with additional EU markets in development for 2026 and beyond. UK patients will gain access to Bloom’s superior formulations and proprietary hardware systems. For more than a decade, Bloom has built its reputation on delivering terpene-rich, flavor-forward strains paired with reliable technology. The brand has an established and leading presence across leading U.S. markets including California, Illinois, Florida, Michigan, Mi
ACI Worldwide Expands Technology Partnership Ecosystem to Power ACI Connetic24.6.2025 08:00:00 EEST | Press release
ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, has expanded its global technology partnership ecosystem to help financial institutions across the globe increase operational resiliency and address evolving regulatory requirements to safeguard the stability of the financial system. Building on strategic partnerships with Microsoft, Red Hat and IBM, ACI is collaborating with MongoDB, a document-oriented NoSQL database, and open source technology NATS from Synadia Communications for the reference architecture of ACI Connetic, ACI’s unified, cloud-native payments platform. These partnerships help extend ACI Connetic far beyond a traditional payments hub, delivering robust, highly functional payment engines to support financial institutions in meeting growingly stringent non-functional requirements and increase resilience against potential disruptions. Banks have come under increasing pressure to future-proof their payments infrastructure, as the industry s
Industrial 3-axis accelerometer has high offset stability24.6.2025 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has introduced a 3-axis accelerometer for the industrial market that combines high offset stability over temperature and time, good linearity, low noise density, and excellent robustness. The SCA3400-D01 XYZ accelerometer is meant for use in industrial applications such as structural health monitoring (SHM), machine control, inertial measurement units, and construction tools and systems. This product will be exhibited at Sensors Converge 2025 to be held at the Santa Clara Convention Center (Booth #716), California from 24 to 26 June 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623994075/en/ [Murata Manufacturing Co., Ltd.] Industrial 3-axis accelerometer The offset stability of an accelerometer refers to the consistency of its output when at rest, but subject to varying temperatures or the effects of aging. Ideally, this output should be zero, but i
Grid Dynamics Announces AI-Powered Engagement Model Enabling Accelerated Business Transformation for Fortune 1000 Enterprises23.6.2025 16:15:00 EEST | Press release
Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (Grid Dynamics)—a prominent technology consulting and digital services provider specializing in AI, platform and product engineering, and digital engagement services—today announced the launch of an innovative AI-powered engagement model for its software engineering services. This new model is specifically engineered to deliver the next level of agility, quality, and accelerated time-to-market for Fortune 1000 enterprises. Grid Dynamics' innovative approach expands its engagement offerings beyond traditional Fixed Price, Time and Materials, and Capacity-based engagements. Key features include: Prompt-driven incremental output: Delivering value through iterative, prompt-guided development. Credit-based service consumption: Pricing aligned with desired outputs rather than effort—offering cost efficiency. AI-benchmarked code quality: Continuous evaluation against industry and client standards—ensuring code quality. Centralized client portal: A s
Live Biotherapeutics at a Crossroad: Novotech White Paper Outlines Opportunities and Early-Stage Challenges23.6.2025 15:05:00 EEST | Press release
As Live Biotherapeutic Products (LBPs) begin to transition from frontier science to clinical reality, Novotech, a leading global CRO and scientific advisory partner has published a new white paper examining the opportunities and challenges shaping this fast-evolving landscape of therapeutic class. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623205345/en/ LBPs, which harness live microorganisms to restore or modulate human health, are being explored across a growing range of indications, from gastrointestinal and metabolic disorders to CNS and oncology. FDA approvals of Rebyota™ and Vowst™ have validated the category but for most biotech sponsors, the journey remains uncertain. According to Novotech’s analysis, over 90% of LBP assets are still in early development stages, and nearly one-third of all trials from 2020 to 2025 have been withdrawn or suspended due to regulatory, manufacturing, or design complexities. Highli
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom